Margaret Ann Marshall

Title: The Innovative Contributions of Margaret Ann Marshall

Introduction

Margaret Ann Marshall is a prominent inventor based in Beverly Hills, CA (US). She has made significant contributions to the field of cancer treatment through her innovative research and patented methods. With a total of 3 patents, her work has the potential to impact the lives of many patients battling cancer.

Latest Patents

Marshall's latest patents include a groundbreaking method of treating cancer with a combination of an anti-CCR4 antibody and a 4-1BB agonist. This patent describes combination therapies that utilize an antibody specifically binding to human CCR4 alongside a selective 4-1BB agonist for effective cancer treatment. Another notable patent focuses on methods of treating cancer, such as melanoma, by administering a CTLA4 antagonist to subjects with a serum C-Reactive Protein (CRP) concentration below a certain threshold. This invention emphasizes the importance of serum CRP concentration as a predictive factor for a subject's response to cancer treatment.

Career Highlights

Throughout her career, Margaret has worked with leading companies in the pharmaceutical industry, including Pfizer Corporation and Kyowa Hakko Kirin Co., Limited. Her experience in these organizations has allowed her to develop and refine her innovative approaches to cancer treatment.

Collaborations

Margaret has collaborated with esteemed colleagues such as Bo Huang and Chia-Yang Lin. These partnerships have further enhanced her research and contributed to the advancement of her patented methods.

Conclusion

Margaret Ann Marshall's contributions to cancer treatment through her innovative patents demonstrate her commitment to improving patient outcomes. Her work continues to inspire future research in the field of oncology.